top of page

Publications (~ 2020)


  1. Oh SY, Choi KH, Kim KM, Jung J, Sex-dependent effects of estrogen pellets in human liver cancer xenograft models, Toxicol. Res., 36, 109-114 (2020)

  2. Heo MJ, Kang SH, Kim YS, Lee JM, Yu J, Kim HR, Lim H, Kim KM, Jung J, Jeong LS, Moon A, Kim SG, UBC12-mediated SREBP-1 neddylation worsens metastatic tumor prognosis, Inter. J. Cancer, 147, 2550-2563 (2020)

  3. Kim KM, Jung J, Upregulation of G protein-coupled estrogen receptor by chrysin-nanoparticles inhibits tumor proliferation and metastasis in triple negative breast cancer xenograft model, Front. Endo., 2020 Sep, 11, 560605, 1-11 (2020).

  4. Lee SY, Lee SK, Jung J, Potentiating activities of chrysin in the therapeutic efficacy of 5-fluorouracil in gastric cancer cells, Onc. Lett., (2020, accepted).


  1. Jung J. Recent advances of MALDI-mass spectrometry imaging in cancer research, Mass Spectrom. Lett. 10(3), 71-78 (2019).

  2. Jung J. Role of G protein-coupled estrogen receptor in cancer progression, Toxicol. Res. 35, 209-214 (2019). 

  3. Jung J, Song DY, Hwang JJ, Park HJ, Lee JS, Song SY, Jeong SY, Choi EK, Induction of p53-mediated senesscence is essential for the eventual anticancer therapeutic effect of RH1, Arch. Pharm. Res, 42, 815-823 (2019).

  4. Lim H, Kim SY, Lee E, Lee SE, Oh S, Jung J, Kim KS, Moon A, Sex-dependent adverse drug reactions to 5-fluorouracil in colorectal cancer, Biol. Pharm. Bull., 42, 594-600 (2019).

  5. Lee HH, Jung J, Moon A, Kang H, Cho H, Antitumor and anti-invasive effect of apigenin on human breast carcinoma through suppression of IL-6 expression, Int J Mol Sci, 20, 3143 (2019).

  6.  Kim HJ, Jang SJ, Jang EY, Jung J, Han E. Investigation of human study and clinical trial of policosanol, KFDC Food, drug & cosmetic, 14(1), 73-82 (2019).

  7. Jang YS, Kim DE, Han E, Jung J, Physiological activities of policosanol extracted from sugarcane wax, Nat. Prod. Sci., 25(4), 293-297 (2019).


  1. Kim ES, Kim SY, Koh M, Lee HM, Kim KM, Jung J, Kim HS, Moon WK, Hwang S, Moon A, C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cancer adhesion and breast cancer progression, Oncogene, 37, 28-38 (2018).

  2. Jung J, Somiya M, Jeong SY, Choi EK, Kuroda S, Low immunogenic bio-nanocapsule based on hepatitis B virus escape mutants, Nanomedicine: Nanotech. Biol. Med., 14(2), 595-600 (2018).

  3. Lim HK, Lee H, Moon A, Kang KT, Jung J, Exploring protocol for breast cancer xenograft model using endothelial colony-forming cells, Transl Cancer Res, 7(5), 1128-1234 (2018).


  1. Shin SH, Park SS, Lee KJ, Ju EJ, Park J, Ko EJ, Jung J, Kuroda S, Hong SM, Hwang JJ, Lee JS, Song SY, Jeong SY, Choi EK, Preclinical evaluation of cisplatin-incorporated bio-nanocapsules as chemoradiotherapy for human hepatocellular carcinoma, Oncol. Rep. 38, 2259-2266 (2017).  

  2. Jung J, Kim KM, Lim HK, Park JS, Establishing a colorectal cancer liver metastasis patient-derived tumor xenograft model for the evaluation of personalized chemotherapy, Annal Surg Treat Res, 93(4) 173-180 (2017).

  3. Kim KM, Lim HK, Shim SH, Jung J, Improved chemotherapeutic efficacy of injectable chrysin encapsulated by copolymer nanoparticles, Int J Nanomedicine, 12, 1917-1925 (2017).

  4. Choi K, Lim HK , Oh SR, Chung WH, Jung J, Anticancer effects of the marine sponge Lipastrotethya sp. extract on wild type and p53 knockout HC16 cells, Evid Based Complement Alternat Med, 2017, 7174858, 1-6 (2017).

  5. Jung J, Anti-cancer effect of marine resources against human colorectal cancer cells, J Food Hyg Saf, 32(1), 70-74 (2017)


  1. Yi DG, Kim MJ, Choi JE, Lee J, Jung J, Huh WK, Chung WH, Yap1 and Skn7 genetically interact with Rad51 in response to oxidant stress and DNA double-strand break in Saccharomyces cerevisiae, Free Radic Bio Med, 101, 424-433 (2016).

  2. Song SY, Kim KP, Jeong SY, Park J, Park J, Jung J, Chung HK, Lee SW, Seo MH, Lee JS, Jung KH, Choi EK, Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer model, Oncotarget, 12668 (2016).

  3. Lim HK, Kim KM, Jeong SY, Choi EK, Jung J, Chrysin increases the therapeutic efficacy of docetaxel and mitigates docetaxel-induced edema, Integr Cancer Ther, May 5 (2016).

  4. Jung J, Emerging utilization of chrysin using nanoscale modification, J Nanomaterials, 2016, ID 2894089, 1-7 (2016).

  5. Choi KH, Jung J, Anti-proliferation effect of Coscinoderma sp. extract on human colon cancer cells, J Food Hyg Saf, 31(4), 294-298 (2016).

  6. Lim HK, Kwon Y, Song J, Kim KM, Kim C, Park MS, Jung J, Anticancer mechanisms of 3-heptylamino-6-allylthiopyridazine and 3-dipentylamino-6-allylthiopyridazine in human colon carcinoma RKO cells, Yakhak Hoeji, 60(3), 101-106 (2016).


  1. Choi J, Ko E, Chung HK, Lee JH, Ju EJ, Lim HK, Park I, Kim KS, Lee JH, Son WC, Lee JS, Jung J, Jeong SY, Song SY, Choi EK, Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs, Int J Nanomedicine, 10, 6121-6132 (2015).

  2. Bae W, Lim HK, Kim KM, Cho H, Lee SY, Jeong CS, Lee HS, Jung J, Apoptosis-inducing activity of marine sponge Haliclona sp. extracts collected from Kosrae in nonsmall cell lung cancer A549 cells, Evid Based Complement Alternat Med, 2015, 717959 (2015).

  3. Liu Q, Jung J, Somiya M, Iijima M, Yoshimoto N, Niimi T, Maturana AD, Shin SH, Jeong SY, Choi EK, Kuroda S, Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy, Int J Nanomedicine, 10, 4159-4172 (2015).

  4. Lee S, Lee HH, Kim J, Jung J, Moon A, Jeong CS, Kang H, Cho H, Anti-tumor effect of Cordyceps militaris in HCV-infected human hepatocarcinoma 7.5 cells, J Microbiol, 53, 468-474 (2015).


  1. Jung J, Human Tumor Xenograft Models for Preclinicl Assessment of Anticancer Drug Development, Toxicol. Res. 30(1), 1-5 (2014)

  2. Jung J, Choi JS, Jeong CS, Inhibitory Activities of Palmatine from Coptis chinensis Against Helicobactor pylori and Gastric Damage, Toxicol. Res. 30(1), 45-48 (2014 Mar)

  3. Kim ES, Cha Y, Ham M, Hwang S, Jung J, Kleemann R. Moon A, Inflammatory lipid sphingosine-1-phosphate upregulates c-reactive protein via C/EBPβ and potentiates breast cancer progression, Oncogene 33(27), 3583-3593 (2014 Jul).

  4. Lim HK, Bae W, Lee HS, Jung J, Anticancer activity of the marine sponge Hyrtios sp. in human colorectal carcinoma RKO cells with different p53 status, BioMed Res. Int. 2014, 413575 (2014)


  1. Jung J, Bae KH, Jeong CS, Anti-helicobacter pylori and antiulcerogenic activities of the root cortex of Paeonia suffruticosa, Biol. Pharm. Bull. 36(10), 1535-1539. (2013 Oct).  


  1. Jung J, Park SJ, Chung HK, Kang HW, Lee SW, Seo MH, Park HJ, Song SY, Jeong SY, Choi EK, Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancer. Int. J. Radioation Oncol. Biol. Phys. (2012) 84, e77-e83.

  2. Jung J, Kim MS, Park SJ, Chung HK, Choi J, Park J, Jin DH, Song SY, Park HJ, Lee DS, Jeong SY, Choi EK, Enhancement of radiotherapeutic efficacy by paclitaxel-loaded pH-sensitive block copolymer micelle. J. Nanomaterials (2012) ID867036, 1-5.

  3. Choi J, Kim HY, Ju EJ, Jung J, Park J, Chung HK, Lee JS, Lee JS, Park HJ, Song SY, Jeong SY, Choi EK, Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. Biomaterials. (2012) 33(16), 4195-4203.

  4. Jung J, Kim EJ, Chung HK, Park HJ, Jeong SY, Choi EK, c-Myc down-regulation in involved in proteasome inhibitor-medicated enhancement of radiotherapeutic efficacy in non-small cell lung cancer. Int. J. Oncol. (2012) 40, 385-390.

  5. Hwang SA, Hwang IY, Jung J, Kang HK, Son KH, Jeong CS, Dipsacussaponin C from Dipsacus asper reduces the risk of gastritis and gastric ulcer in rats. Food Nut. Sci. 3, 931-341 (2012 Jul).

  6. Matsuo H, Yoshimoto N, Iijima M, Niimi T, Jung J, Jeong SY, Choi EK, Sewaki T, Arakawa T, Kuroda S, Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cells. Int. J. Nanomed. 7, 3341-3350. (2012).

  7. Choi J, Woo HN, Ju EJ, Jung J, Chung HK, Park J, Park SS, Shin SH, Park HJ, Lee JS, Song SY, Jeong SY, Choi EK, Immunocytes as a biocarrier to delivery therapeutic and imaging contrast agents to tumors. J. Nanomaterials ID 863704. (2012)

  8. Yamada M, Oeda A, Jung J, Iijima N, Yoshimoto N, Niimi T, Jeong SY, Choi EK, Tanizawa K, Kuroda S, Hepatitis B virus envelope L protein-derived bio-nanocapsules: Mechanisms of cellular attachment and entry into human hepatic cells. J. Control. Release 160, 322-329. (2012 Jun 10)

  9. Somiya M, Yoshimoto N, Iijima M, Niimi T, Dewa T, Jung J, Kuroda S, Targeting of polyplex to human hepatic cells by bio-nanocapsules, hepatitis B virus surface antigen L protein particles. Bioorg. Med. Chem. 20, 3873-3879. (2012 Jun 15)

  10. Woo HN, Chung HK, Ju EJ, Jung J, Kang HW, Lee SW, Seo MH, Lee JS, Lee JS, Park HJ, Song SY, Jeong SY, Choi EK, Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy. Int. J. Nanomed. 7, 2197-2208. (2012 Apr)

Please reload

bottom of page